Paper41300985
Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.
De Lucia SS and 8 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Papers, record 41300985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07486492 | Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer | Results |
Source ClinicalTrials.gov
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31578522 | The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. | Nature | 2019 | https://conductscience.org/library/papers/31578522 | PubMed |
| 2 | 36115181 | Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. | Drug Resist Updat | 2022 | https://conductscience.org/library/papers/36115181 | PubMed |
| 3 | 29567829 | The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29567829 | PubMed |
| 4 | 32145242 | The link "Cancer and autoimmune diseases" in the light of microbiota: Evidence of a potential culprit. | Immunol Lett | 2020 | https://conductscience.org/library/papers/32145242 | PubMed |
| 5 | 24899628 | Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. | Protein Eng Des Sel | 2014 | https://conductscience.org/library/papers/24899628 | PubMed |
| 6 | 37432351 | Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. | Nutrients | 2023 | https://conductscience.org/library/papers/37432351 | PubMed |
| 7 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 8 | 33906958 | Therapeutic potential of microbial modulation in pancreatic cancer. | Gut | 2021 | https://conductscience.org/library/papers/33906958 | PubMed |
| 9 | 31398337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
| 10 | 35398347 | Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. | Gastroenterology | 2022 | https://conductscience.org/library/papers/35398347 | PubMed |
| 11 | 38662232 | Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/38662232 | PubMed |
| 12 | 40376462 | A comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40376462 | PubMed |
| 13 | 26791914 | Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis. | J Intern Med | 2016 | https://conductscience.org/library/papers/26791914 | PubMed |
| 14 | 38108398 | Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation. | Cancer Immunol Res | 2024 | https://conductscience.org/library/papers/38108398 | PubMed |
| 15 | 24321381 | Oncolytic vaccinia virus in combination with radiation shows synergistic antitumor efficacy in pancreatic cancer. | Cancer Lett | 2014 | https://conductscience.org/library/papers/24321381 | PubMed |
| 16 | 36309208 | Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy. | Gastroenterology | 2023 | https://conductscience.org/library/papers/36309208 | PubMed |
| 17 | 25423447 | Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors. | Hum Gene Ther | 2015 | https://conductscience.org/library/papers/25423447 | PubMed |
| 18 | 29132246 | Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer. | J Drug Target | 2018 | https://conductscience.org/library/papers/29132246 | PubMed |
| 19 | 29636538 | The gut microbiota influences anticancer immunosurveillance and general health. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29636538 | PubMed |
| 20 | 35756645 | Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review. | Front Oncol | 2022 | https://conductscience.org/library/papers/35756645 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891339 | Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42891339 | PubMed |
| 42651018 | Metabolic Syndrome and Pancreatic Cancer: Linking Insulin Resistance, Inflammation, and Carcinogenesis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42651018 | PubMed |
| 42122957 | Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42122957 | PubMed |
| 42073615 | Microbiome and Diet Interplay: An Emerging Frontier in PDAC Diagnosis and Prevention. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073615 | PubMed |
| 41471890 | Role of Probiotics in Enhancing Immune Function and Improving the Effectiveness of Treatments for Pancreatic Cancer. | Microorganisms | 2025 | https://conductscience.org/library/papers/41471890 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300985
GET https://conductscience.org/api/papers/v1/41300985/references?page=2